CCL2 and stroke disorder: In addition, SHBG could markedly suppress lipopolysaccharide-induced inflammatory biomarkers in macrophages and adipocytes, such as monocyte chemoattractant protein-1, TNFα, and IL-6 [50], which have been reported to be closely related to stroke risk and prognosis [51,52].